Use of hippocampus multi-whip pill in preparation of medicine for preventing and treating Alzheimer disease
Hippocampus pills significantly reduce acetylcholinesterase activity by improving motor and cognitive function in AD models. Clinical trials have shown that the effects are similar to those of conventional drugs, providing a new strategy for the treatment of Alzheimer's disease.
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- SHENYANG KANGDA PHARM GRP CO LTD OF SHENYANG
- Filing Date
- 2026-05-15
- Publication Date
- 2026-07-17
AI Technical Summary
There is a lack of effective drugs for the prevention and treatment of Alzheimer's disease in the current technology, and existing treatments have failed to effectively control the progression of the disease. Traditional Chinese medicine has unique advantages in this field, and the application of Hippocampus Multi-Bian Pill is a new treatment strategy.
The application of Hippocampus Multi-Whip Pill in the preparation of drugs for the prevention and treatment of Alzheimer's disease has shown significant improvement in motor ability and cognitive function through experiments on zebrafish and female AD model mice. Clinical trials have shown similar effects to conventional drugs.
Hippocampus multi-whip pills significantly improve motor speed and cognitive function in AD models, and reduce acetylcholinesterase activity. Clinical trials have shown certain therapeutic effects, providing a new approach to the treatment of Alzheimer's disease.
Smart Images
Figure FT_1 
Figure SMS_1 
Figure SMS_2